Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Vanessa L, Merker"'
Autor:
Vanessa L. Merker, Pamela Knight, Heather B. Radtke, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin, Justin T. Jordan
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Introduction The neurofibromatoses (NF) are a group of rare, genetic diseases sharing a predisposition to develop multiple benign nervous system tumors. Given the wide range of NF symptoms and medical specialties involved in NF care, we soug
Externí odkaz:
https://doaj.org/article/d9cfb3ef215844979fe83ad1541dab7a
Autor:
Heather B. Radtke, Bonita P. Klein-Tasman, Vanessa L. Merker, Pamela Knight, Nicole J. Ullrich, Justin T. Jordan, Bruce Korf, Scott R. Plotkin
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-6 (2021)
Abstract Purpose The coronavirus disease 2019 (COVID-19) pandemic has had unprecedented impact on the provision of medical care for genetic disorders. The purpose of this study was to assess the effects of the pandemic on neurofibromatosis (NF) care
Externí odkaz:
https://doaj.org/article/3c97f009555e4e778a151ab8c261fa09
Autor:
Vanessa L. Merker, Annie Dai, Heather B. Radtke, Pamela Knight, Justin T. Jordan, Scott R. Plotkin
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Our primary aim was to assess the ability of a non-profit foundation-sponsored clinic network to facilitate access to specialized care for patients with neurofibromatoses (NF), a group of neurogenetic disorders including NF1, NF2,
Externí odkaz:
https://doaj.org/article/cd7f70c449e4481381a22d02d59e6c96
Publikováno v:
Journal of Applied Research in Intellectual Disabilities. 36:354-365
Autor:
Scott R. Plotkin, Ludwine Messiaen, Eric Legius, Patrice Pancza, Robert A. Avery, Jaishri O. Blakeley, Dusica Babovic-Vuksanovic, Rosalie Ferner, Michael J. Fisher, Jan M. Friedman, Marco Giovannini, David H. Gutmann, Clemens Oliver Hanemann, Michel Kalamarides, Hildegard Kehrer-Sawatzki, Bruce R. Korf, Victor-Felix Mautner, Mia MacCollin, Laura Papi, Katherine A. Rauen, Vincent Riccardi, Elizabeth Schorry, Miriam J. Smith, Anat Stemmer-Rachamimov, David A. Stevenson, Nicole J. Ullrich, David Viskochil, Katharina Wimmer, Kaleb Yohay, Susan M. Huson, Pierre Wolkenstein, D. Gareth Evans, Monique Anten, Arthur Aylsworth, Diana Baralle, Sebastien Barbarot, Fred Barker, Shay Ben-Shachar, Amanda Bergner, Didier Bessis, Ignacio Blanco, Catherine Cassiman, Patricia Ciavarelli, Maurizio Clementi, Thierry Frébourg, Alicia Gomes, Dorothy Halliday, Chris Hammond Helen Hanson Arvid Heiberg, Pascal Joly, Justin T. Jordan, Matthias Karajannis, Daniela Kroshinsky, Margarita Larralde, Conxi Lázaro, Lu Le, Michael Link, Robert Listernick, Conor Mallucci, Vanessa L. Merker, Christopher Moertel, Amy Mueller, Joanne Ngeow, Rianne Oostenbrink, Roger Packer, Allyson Parry, Juha Peltonen, Dominique Pichard, Bruce Poppe, Nilton Rezende, Luiz Oswaldo Rodrigues, Tena Rosser, Martino Ruggieri, Eduard Serra, Verena Steinke-Lange, Stavros Michael Stivaros, Amy Taylor, Jaan Toelen, James Tonsgard, Eva Trevisson, Meena Upadhyaya, Ali Varan, Meredith Wilson, Hao Wu, Gelareh Zadeh
Publikováno v:
Genetics in Medicine, 24(9), 1967-1977. Lippincott Williams & Wilkins
PURPOSE: Neurofibromatosis type 2 (NF2) and schwannomatosis (SWN) are genetically distinct tumor predisposition syndromes with overlapping phenotypes. We sought to update the diagnostic criteria for NF2 and SWN by incorporating recent advances in gen
Autor:
Vanessa L. Merker, Justeen K. Hyde, Abigail Herbst, Amanda K. Solch, David C. Mohr, Lauren Gaj, Kelly Dvorin, Eileen M. Dryden
Publikováno v:
Journal of General Internal Medicine. 37:33-41
Background Despite increasing commitment to patient engagement in research, evaluation of the impact of these efforts on research processes, products, and teams is limited. Objective To explore the impacts of engaging patients as consultants to resea
Autor:
K. Ina Ly, Vanessa L. Merker, Wenli Cai, Miriam A. Bredella, Alona Muzikansky, Raquel D. Thalheimer, Jennifer Liwei Da, Christina C. Orr, Hamilton P. Herr, Mary E. Morris, Connie Y. Chang, Gordon J. Harris, Scott R. Plotkin, Justin T. Jordan
Publikováno v:
Neurology
Background and ObjectivesInternal neurofibromas, including plexiform neurofibromas (PNF), can cause significant morbidity in patients with neurofibromatosis type 1 (NF1). PNF growth is most pronounced in children and young adults, with more rapid gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3177b5df8423d009c622fd170a97a8fe
https://europepmc.org/articles/PMC9969927/
https://europepmc.org/articles/PMC9969927/
Autor:
Melissa Baker, Mary Anne Toledo-Tamula, Claas Rohl, Stephanie Reda, Pamela L. Wolters, Vanessa L. Merker, Tena Rosser, Barbara Franklin, Beverly Oberlander, Stephanie Reeve, Ana-Maria Vranceanu, Staci Martin, Nour Al Ghriwati, Gregg Erickson, Dale Berg
Publikováno v:
American Journal of Medical Genetics. Part a
The coronavirus pandemic increased anxiety and stress and prevented access to health care worldwide; it is unclear how COVID‐19 affected adults with a multisystem genetic disorder such as neurofibromatosis (NF). An anonymous online survey was distr
Autor:
Staci Martin, Elizabeth K. Schorry, James H. Tonsgard, Heather L. Thompson, Pamela L. Wolters, Christopher J. Funes, Andrea Baldwin, Cynthia M. Hingtgen, Barbara Franklin, Stephanie Reeve, Taryn Allen, Taylor F. Smith, Kimberley S. Koetsier, Ana-Maria Vranceanu, Vanessa L. Merker, Carolina Barnett
Publikováno v:
Neurology
ObjectiveTo review and recommend patient-reported outcome (PRO) measures assessing multidimensional domains of quality of life (QoL) to use as clinical endpoints in medical and psychosocial trials for children and adults with neurofibromatosis (NF) t
Autor:
Beverly Oberlander, Pamela L. Wolters, Traceann Rose, Maureen Hussey, Raquel Thalheimer, Tracy Wirtanen, Irene Moss, Andrés J. Lessing, Scott R. Plotkin, Vanessa L. Merker, Andrea M. Gross
Publikováno v:
Neurology
ObjectiveAs part of an evaluation of the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration patient representative program, we surveyed REiNS members to (1) identify facilitators and barriers to involving